Paclitaxel Market by Size, Type and Application and Focuses on top Key Players to 2025
The Paclitaxel
Market Analysis includes market development history, product and
technology developments, competitive landscape analysis, key countries
development status, market development trend, and market comparison analysis.
Paclitaxel belongs to the group of medications called antineoplastic and is
widely used in the treatment of cancers. It functions by preventing the growth
of cancer cells and is utilized in the treatment of various types of cancers
which include ovarian cancer, AIDS-related Kaposi’s sarcoma, Oesophageal cancer,
stomach cancer, lung cancer, ovarian cancer, cervical cancer, non-small cell
lung cancer, prostate cancer, testicular cancer, and pancreatic cancer.
The major factors driving the growth of the global paclitaxel
market includes the better effectiveness of paclitaxel injections as well as
growing prevalence of cancer all over the world. However, opposing drug
reactions related to the drug along with the advent of targeted treatment, new
anti-cancer drugs, and personalized medications are expected to be few of the
major which might hinder the growth of the overall market over the next few
years.
The opportunities for the global paclitaxel market lies in its
potential to be used for the ailment of several types of cancer. According to
the WHO, breast cancer accounted for approximately 5,21,000 deaths whereas
stomach cancer accounted for approximately 7,23,000 deaths alone in the year
2012. Paclitaxel finds huge application in the treatment of both these types of
cancers and the growing prevalence of cancer would give rise to increased use
of this drug for the process of treatment. It is also expected that the global
paclitaxel market has a high threat of substitutes and extensive research and
development is being carried out in anti-cancer drugs.
North America accounted for the maximum demand for the Global
Paclitaxel Industry in the recent past. Growing population along
with rapid industrialization and increasing disposable incomes in countries
such as India, South Korea, Indonesia, Vietnam, China, Japan, and Malaysia are
estimated to benefit the regional market growth. Asia-Pacific and Europe are
also expected to observe huge growth in the future. Initiatives taken by the
government in the end-use industries are anticipated to provide significant
gains in both the regions. Latin America is estimated to be the most rapidly
emerging region for the global paclitaxel market over the next few years.
The key market players in the global paclitaxel industry are
investing heavily in the research & development activities. These players
are introducing new innovative strategies for marketing as well as new product
developments. Through these, strategies, they are trying to gain a competitive
advantage over the other market players in the industry. The major companies
operating in the market include Abraxis Bio Science Inc., Abbott Laboratories,
Onco therapies Ltd, Sagent Pharmaceuticals, Celgene, Fresenius Kabi Oncology
Ltd, Bioxel Pharma, Inc., Hospira, Inc., OncoGenex Pharmaceuticals, Inc.,
Bristol-Myers Squibb Co., Indena S.p.A., and Novasep. Global paclitaxel
industry market research report is a professional and in-depth analysis of the
overall industry. The industry overview includes paclitaxel definition,
application, classification, industry chain structure, industry policy
analysis, industry overview, and industry news analysis.
Download
PDF Brochure on recent studies 2018 @ https://www.millioninsights.com/industry-reports/paclitaxel-market/request-sample
Comments
Post a Comment